Related Experiment Videos
Exfoliative dermatitis secondary to tobramycin sulfate
Cutis
|May 1, 1991
Summary
Exfoliative dermatitis was linked to tobramycin, an antibiotic. Rechallenging the patient confirmed tobramycin as the cause of this severe skin reaction.
Area of Science:
- Dermatology
- Pharmacology
- Clinical Medicine
Background:
- Exfoliative dermatitis is a severe skin condition characterized by widespread scaling and peeling.
- Tobramycin is an aminoglycoside antibiotic commonly used to treat serious bacterial infections.
Observation:
- A patient developed exfoliative dermatitis during treatment with intravenous and intraperitoneal tobramycin.
- The patient's complex medication regimen included multiple drugs, making initial attribution challenging.
Findings:
- Rechallenge with tobramycin, after initial suspicion, reproduced the exfoliative dermatitis.
- Subsequent rechallenge at another hospital further confirmed tobramycin as the causative agent.
Implications:
- This case highlights the potential for tobramycin to induce exfoliative dermatitis, even in complex clinical scenarios.
- Clinicians should consider tobramycin as a potential cause of exfoliative dermatitis in patients receiving this antibiotic.